Md Masudul Hassan
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Md Masudul Hassan has a total of 70 co-authors. Here are the top co-authors by number of shared publications:
- Minhaj Rahim Choudhury
Department of Rheumatology Bangladesh Medical University Dhaka Bangladesh
6 shared publications - Mohammad Abul Kalam Azad
Department of Rheumatology Bangladesh Medical University Dhaka Bangladesh
4 shared publications Nazrul Islam
Professor, Department of Rheumatology, Bangladesh Medical university, Dhaka, Bangladesh
4 shared publicationsAbu Shahin
Faculty of Behavioral, Management and Social Sciences, Department Psychology, Health and Technology, University of Twente, PO Box 217, 7500 AE, Enschede, The Netherlands
2 shared publicationsAbul Khair Ahmedullah
Assistant professor, department of Rheumatology, Bangabandhu Sheikh Mujib Medical University, Shahbag, Dhaka
2 shared publicationsHumayun Sattar
Department of Microbiology, Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh
2 shared publications
Latest Publications
- Open Access
- 11 May 2026
- Published by Wiley in Clinical Case Reports
- Vol. 14 (5)
Severe Multisystem Thrombotic Phenotype Associated With Protein C Deficiency in A Young Woman: A Case Report
Severe protein C deficiency may present with recurrent multisystem thrombosis, including catastrophic mesenteric venous thrombosis in young adults. Early clinical suspicion, prompt imaging, and thrombophilia screening are essential for timely diagnosis and life‐saving intervention. Lifelong anticoagulation and close follow‐up are crucial to prevent recurrence and improve outcomes.
- 11 May 2026
- Published by Wiley in Clinical Case Reports
- Vol. 14 (5)
Open AccessSevere Multisystem Thrombotic Phenotype Associated With Protein C Deficiency in A Young Woman: A Case Report
Severe protein C deficiency may present with recurrent multisystem thrombosis, including catastrophic mesenteric venous thrombosis in young adults. Early clinical suspicion, prompt imaging, and thrombophilia screening are essential for timely diagnosis and life‐saving intervention. Lifelong anticoagulation and close follow‐up are crucial to prevent recurrence and improve outcomes.
- 7 May 2026
- Published by Bangladesh Academy of Sciences in Bangladesh Journal of Medicine
- Vol. 37 (2) , 128-136
The Frequency of Thiopurine Methyl-transferase Polymorphism in Systemic Lupus Erythematosus Patients and Its Association with Azathioprine Induced Adverse Effects
Background: Thiopurine S-methyltransferase (TPMT) is the rate-limiting enzyme in the metabolism of azathioprine (AZA). Genetic polymorphisms in TPMT can increase the risk of adverse effects from AZA. AZA is commonly used as an immunosuppressant to maintain remission in patients with Systemic Lupus Erythematosus (SLE). This study aims to investigate the frequency of TPMT polymorphisms in SLE patients . Methods: This post hoc case–control study was conducted at Bangladesh Medical University and the University of Dhaka from July 2022 to January 2023. Adults (18–65 years) fulfilling American College of Rheumatology criteria for SLE were enrolled. TPMT genotyping was performed using polymerase chain reaction–restriction fragment length polymorphism (PCR–RFLP). Patients were assigned to AZA (n = 120) or non-AZA (n = 217) groups. Exclusion criteria included recent blood transfusion, use of drugs causing myelosuppression or interfering with AZA/6-MP metabolism, concomitant cyclosporine or mycophenolate mofetil therapy, and pregnancy. AZA was initiated for clinical indications at 1 mg/kg/day, escalated to 2 mg/kg/day after two weeks, and continued with four-weekly assessments for 12 week. Results: The mean age of the AZA group was 28.4 ± 9.5 years; 96.65% were female. TPMT polymorphisms were detected in 12 patients (3.56%), all carrying the TPMT*3C allele. Ten patients developed myelosuppression; among AZA-treated patients with TPMT polymorphisms, six of seven (85.7%) developed myelosuppression. Overall, 16 patients (14.4%) develop AZA-related adverse effects.Conclusion: TPMT polymorphisms were uncommon in this study but strongly associated with AZA-induced myelosuppression. Pre-treatment genotyping may improve the safety of AZA therapy in SLE patients. Bangladesh J Medicine 2026; 37(2): 128-136
- 7 May 2026
- Published by Bangladesh Academy of Sciences in Bangladesh Journal of Medicine
- Vol. 37 (2) , 128-136
The Frequency of Thiopurine Methyl-transferase Polymorphism in Systemic Lupus Erythematosus Patients and Its Association with Azathioprine Induced Adverse Effects
Background: Thiopurine S-methyltransferase (TPMT) is the rate-limiting enzyme in the metabolism of azathioprine (AZA). Genetic polymorphisms in TPMT can increase the risk of adverse effects from AZA. AZA is commonly used as an immunosuppressant to maintain remission in patients with Systemic Lupus Erythematosus (SLE). This study aims to investigate the frequency of TPMT polymorphisms in SLE patients . Methods: This post hoc case–control study was conducted at Bangladesh Medical University and the University of Dhaka from July 2022 to January 2023. Adults (18–65 years) fulfilling American College of Rheumatology criteria for SLE were enrolled. TPMT genotyping was performed using polymerase chain reaction–restriction fragment length polymorphism (PCR–RFLP). Patients were assigned to AZA (n = 120) or non-AZA (n = 217) groups. Exclusion criteria included recent blood transfusion, use of drugs causing myelosuppression or interfering with AZA/6-MP metabolism, concomitant cyclosporine or mycophenolate mofetil therapy, and pregnancy. AZA was initiated for clinical indications at 1 mg/kg/day, escalated to 2 mg/kg/day after two weeks, and continued with four-weekly assessments for 12 week. Results: The mean age of the AZA group was 28.4 ± 9.5 years; 96.65% were female. TPMT polymorphisms were detected in 12 patients (3.56%), all carrying the TPMT*3C allele. Ten patients developed myelosuppression; among AZA-treated patients with TPMT polymorphisms, six of seven (85.7%) developed myelosuppression. Overall, 16 patients (14.4%) develop AZA-related adverse effects.Conclusion: TPMT polymorphisms were uncommon in this study but strongly associated with AZA-induced myelosuppression. Pre-treatment genotyping may improve the safety of AZA therapy in SLE patients. Bangladesh J Medicine 2026; 37(2): 128-136
- Open Access
- 24 February 2026
- Published by Wiley
Severe protein C deficiency with Mesenteric Thrombosis - A Rare report from a developing country
Severe protein C deficiency with Mesenteric Thrombosis - A Rare report from a developing countryAkash Ahmed Alif 1, Mohammad Abul Kalam Azad2, Tumpa Kundo3, Masudul Hassan4, Minhaj Rahim Choudhury5, Shamim Ahmed6.1. Resident, Department of Rheumatology, Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh, akash.alif@gmail.com, https://orcid.org/0009-0009-8560-14732. Associate Professor, Department of Rheumatology, Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh, akazadpg74@bsmmu.edu.bd*, http://orcid.org/0009-0006-8675-82433. Resident, Department of Rheumatology, Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh, kundutumpa12@gmail.com, kundutumpa12@gmail.com4. Associate Professor, Department of Rheumatology, Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh, masud292@yahoo.com, https://orcid.org/0000-0002-9048-295X5. Professor, Department of Rheumatology, Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh, drminhaj11@gmail.com, https://orcid.org/0000-0002-8695-52406. Professor Shamim Ahmed, Dean, Faculty of Medicine, Bangabandhu Sheikh Mujib Medical University, shamim46@hotmail.com, https://orcid.org/0000-0002-0616-5821*Corresponding author: Mohammad Abul Kalam Azad, Associate Professor, Department of Rheumatology, Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh, M +8801911099075, akazadpg74@bsmmu.edu.bd
- 24 February 2026
- Published by Wiley
Open AccessSevere protein C deficiency with Mesenteric Thrombosis - A Rare report from a developing country
Severe protein C deficiency with Mesenteric Thrombosis - A Rare report from a developing countryAkash Ahmed Alif 1, Mohammad Abul Kalam Azad2, Tumpa Kundo3, Masudul Hassan4, Minhaj Rahim Choudhury5, Shamim Ahmed6.1. Resident, Department of Rheumatology, Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh, akash.alif@gmail.com, https://orcid.org/0009-0009-8560-14732. Associate Professor, Department of Rheumatology, Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh, akazadpg74@bsmmu.edu.bd*, http://orcid.org/0009-0006-8675-82433. Resident, Department of Rheumatology, Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh, kundutumpa12@gmail.com, kundutumpa12@gmail.com4. Associate Professor, Department of Rheumatology, Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh, masud292@yahoo.com, https://orcid.org/0000-0002-9048-295X5. Professor, Department of Rheumatology, Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh, drminhaj11@gmail.com, https://orcid.org/0000-0002-8695-52406. Professor Shamim Ahmed, Dean, Faculty of Medicine, Bangabandhu Sheikh Mujib Medical University, shamim46@hotmail.com, https://orcid.org/0000-0002-0616-5821*Corresponding author: Mohammad Abul Kalam Azad, Associate Professor, Department of Rheumatology, Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh, M +8801911099075, akazadpg74@bsmmu.edu.bd
- Open Access
- 1 January 2026
- Published by Wiley in Case Reports in Neurological Medicine
- Vol. 2026 (1)
Cerebral Venous Sinus Thrombosis With Bilateral Blindness in Systemic Lupus Erythematosus: A Case Report
Cerebral venous sinus thrombosis (CVST) is an uncommon but potentially life‐threatening neurological complication of systemic lupus erythematosus (SLE) that requires prompt recognition and treatment. We report the case of an 18‐year‐old Bangladeshi woman with established SLE who presented with a 10‐day history of severe headache followed by rapidly progressive bilateral proptosis and sudden, painless bilateral visual loss. Neurological examination revealed complete bilateral visual loss, bilateral ptosis, restricted extraocular movements and multiple cranial nerve deficits. She had active SLE with severe thrombocytopaenia and haematological involvement. Brain magnetic resonance imaging and magnetic resonance venography demonstrated extensive thrombosis involving the superior sagittal, bilateral transverse and sigmoid and cavernous sinuses. Antiphospholipid antibody testing, including lupus anticoagulant, anticardiolipin antibodies and Anti‐β2‐glycoprotein I antibodies, was negative. The patient received therapeutic anticoagulation, high‐dose corticosteroids and immunosuppressive therapy with rituximab, followed by haematological and neurological improvement and subsequent recanalisation of the thrombosed dural venous sinuses. However, bilateral visual loss persisted, with optic disc pallor and optic atrophy. Optical coherence tomography, visual evoked potential testing, dedicated orbital imaging and formal neuro‐ophthalmological assessment were not performed; therefore, the precise mechanism of visual loss could not be definitively established. Nevertheless, ischaemic optic neuropathy was considered the most likely mechanism given the clinical presentation and extensive CVST. This case highlights that extensive CVST may occur in active SLE despite negative antiphospholipid antibody testing. It underscores the importance of early neuroimaging, timely anticoagulation and appropriate immunosuppressive therapy to minimise the risk of persistent neurological and visual sequelae.
- 1 January 2026
- Published by Wiley in Case Reports in Neurological Medicine
- Vol. 2026 (1)
Open AccessCerebral Venous Sinus Thrombosis With Bilateral Blindness in Systemic Lupus Erythematosus: A Case Report
Cerebral venous sinus thrombosis (CVST) is an uncommon but potentially life‐threatening neurological complication of systemic lupus erythematosus (SLE) that requires prompt recognition and treatment. We report the case of an 18‐year‐old Bangladeshi woman with established SLE who presented with a 10‐day history of severe headache followed by rapidly progressive bilateral proptosis and sudden, painless bilateral visual loss. Neurological examination revealed complete bilateral visual loss, bilateral ptosis, restricted extraocular movements and multiple cranial nerve deficits. She had active SLE with severe thrombocytopaenia and haematological involvement. Brain magnetic resonance imaging and magnetic resonance venography demonstrated extensive thrombosis involving the superior sagittal, bilateral transverse and sigmoid and cavernous sinuses. Antiphospholipid antibody testing, including lupus anticoagulant, anticardiolipin antibodies and Anti‐β2‐glycoprotein I antibodies, was negative. The patient received therapeutic anticoagulation, high‐dose corticosteroids and immunosuppressive therapy with rituximab, followed by haematological and neurological improvement and subsequent recanalisation of the thrombosed dural venous sinuses. However, bilateral visual loss persisted, with optic disc pallor and optic atrophy. Optical coherence tomography, visual evoked potential testing, dedicated orbital imaging and formal neuro‐ophthalmological assessment were not performed; therefore, the precise mechanism of visual loss could not be definitively established. Nevertheless, ischaemic optic neuropathy was considered the most likely mechanism given the clinical presentation and extensive CVST. This case highlights that extensive CVST may occur in active SLE despite negative antiphospholipid antibody testing. It underscores the importance of early neuroimaging, timely anticoagulation and appropriate immunosuppressive therapy to minimise the risk of persistent neurological and visual sequelae.
- Open Access
- 1 October 2025
- Published by Edorium Journals Pvt. Ltd. in International Journal of Case Reports and Images
- Vol. 16 (2) , 40-45
Membranous nephropathy (MN) concurrent chronic inflammatory demyelinating polyneuropathy (CIDP) in a Bangladeshi male
Introduction: Chronic inflammatory demyelinating polyneuropathy (CIDP) is an acquired autoimmune disorder of the peripheral nervous system, while membranous nephropathy (MN) is a glomerular disease that may develop from exogenous risks or autoimmune conditions. Their coexistence is extremely rare and poorly understood. Case Report: We report a 55-year-old male from Bangladesh presenting with progressive symmetrical muscle weakness and both motor and sensory impairment in all four limbs. Nerve conduction studies demonstrated features consistent with inflammatory demyelinating polyneuropathy, and cerebrospinal fluid analysis revealed albuminocytological dissociation. The patient also developed nephrotic-range proteinuria; renal biopsy confirmed the diagnosis of membranous nephropathy. He was treated with pulse methylprednisolone and intravenous cyclophosphamide, resulting in improvement in both muscle strength and proteinuria, though sensory deficits persisted. Conclusion: This rare case of concurrent CIDP and MN suggests a shared autoimmune mechanism involving nerves and kidneys. Early recognition and treatment are essential to prevent irreversible neurological and renal damage, especially in resource-limited settings.
- 1 October 2025
- Published by Edorium Journals Pvt. Ltd. in International Journal of Case Reports and Images
- Vol. 16 (2) , 40-45
Open AccessMembranous nephropathy (MN) concurrent chronic inflammatory demyelinating polyneuropathy (CIDP) in a Bangladeshi male
Introduction: Chronic inflammatory demyelinating polyneuropathy (CIDP) is an acquired autoimmune disorder of the peripheral nervous system, while membranous nephropathy (MN) is a glomerular disease that may develop from exogenous risks or autoimmune conditions. Their coexistence is extremely rare and poorly understood. Case Report: We report a 55-year-old male from Bangladesh presenting with progressive symmetrical muscle weakness and both motor and sensory impairment in all four limbs. Nerve conduction studies demonstrated features consistent with inflammatory demyelinating polyneuropathy, and cerebrospinal fluid analysis revealed albuminocytological dissociation. The patient also developed nephrotic-range proteinuria; renal biopsy confirmed the diagnosis of membranous nephropathy. He was treated with pulse methylprednisolone and intravenous cyclophosphamide, resulting in improvement in both muscle strength and proteinuria, though sensory deficits persisted. Conclusion: This rare case of concurrent CIDP and MN suggests a shared autoimmune mechanism involving nerves and kidneys. Early recognition and treatment are essential to prevent irreversible neurological and renal damage, especially in resource-limited settings.
- Open Access
- 8 March 2022
- Published by Springer Nature in Tropical Medicine and Health
- Vol. 50 (1) , 1-10
Post-chikungunya arthritis: a longitudinal study in a tertiary care hospital in Bangladesh
Background and objective: To identify the clinical patterns and consequences of post-chikungunya arthritis was the study's objective. Methods: This longitudinal study was carried out among 143 Chikungunya virus (CHIKV) infected adult patients at the rheumatology department, Bangabandhu Sheikh Mujib Medical University (BSMMU), Dhaka, Bangladesh, during the outbreak of CHIKV infection in 2017. The disease was categorized into three phases: acute or febrile (lasting up to 10 days), subacute (11–90 days), and chronic (> 90 days). Patients who progressed towards the chronic phase were followed up to 1-year. Post-CHIKV de novo chronic inflammatory rheumatisms (CIRs) were characterized by persistent mono or oligoarthritis, undifferentiated polyarthritis, or meet the criteria rheumatoid arthritis (RA) or Spondyloarthritis (SpA). In addition, functional status was assessed by the validated Bangla version of the Health Assessment Questionnaire (HAQ). Results: Mean age was 43.3 ± 11.5 years, and 51.0% were male. Within 1-year follow-up, 60 (41.9%) patients were suffering from arthralgia/ arthritis. Of them 52 patients did not have any pre-existing arthralgia/arthritis. 35 (65.3%) had undifferentiated arthritis, 10 (19.2%) had SpA, and 7 (13.5%) had RA. Patients with pre-existing rheumatological disorders, 6(4.2%) had SpA, 1(0.7%) had RA and 1(0.7%) had osteoarthritis. Polyarthralgia (n = 33, 55.0%) and polyarthritis (n = 20, 33.3%) were the main presentations. Female gender (OR: 0.45; CI: 0.21–0.96), positive IgG (OR: 0.30; CI: 0.12–0.76), and moderate to severe functional disability (OR: 3.46; CI: 1.62–7.40) were independent predictors of developing chronic post-CHIKV rheumatism. Conclusions: At 1-year follow-up, more than one-third of the patients remained symptomatic. Female gender, positive IgG, and moderate to severe functional disability contributed to the development of chronicity.
- 8 March 2022
- Published by Springer Nature in Tropical Medicine and Health
- Vol. 50 (1) , 1-10
Open AccessPost-chikungunya arthritis: a longitudinal study in a tertiary care hospital in Bangladesh
Background and objective: To identify the clinical patterns and consequences of post-chikungunya arthritis was the study's objective. Methods: This longitudinal study was carried out among 143 Chikungunya virus (CHIKV) infected adult patients at the rheumatology department, Bangabandhu Sheikh Mujib Medical University (BSMMU), Dhaka, Bangladesh, during the outbreak of CHIKV infection in 2017. The disease was categorized into three phases: acute or febrile (lasting up to 10 days), subacute (11–90 days), and chronic (> 90 days). Patients who progressed towards the chronic phase were followed up to 1-year. Post-CHIKV de novo chronic inflammatory rheumatisms (CIRs) were characterized by persistent mono or oligoarthritis, undifferentiated polyarthritis, or meet the criteria rheumatoid arthritis (RA) or Spondyloarthritis (SpA). In addition, functional status was assessed by the validated Bangla version of the Health Assessment Questionnaire (HAQ). Results: Mean age was 43.3 ± 11.5 years, and 51.0% were male. Within 1-year follow-up, 60 (41.9%) patients were suffering from arthralgia/ arthritis. Of them 52 patients did not have any pre-existing arthralgia/arthritis. 35 (65.3%) had undifferentiated arthritis, 10 (19.2%) had SpA, and 7 (13.5%) had RA. Patients with pre-existing rheumatological disorders, 6(4.2%) had SpA, 1(0.7%) had RA and 1(0.7%) had osteoarthritis. Polyarthralgia (n = 33, 55.0%) and polyarthritis (n = 20, 33.3%) were the main presentations. Female gender (OR: 0.45; CI: 0.21–0.96), positive IgG (OR: 0.30; CI: 0.12–0.76), and moderate to severe functional disability (OR: 3.46; CI: 1.62–7.40) were independent predictors of developing chronic post-CHIKV rheumatism. Conclusions: At 1-year follow-up, more than one-third of the patients remained symptomatic. Female gender, positive IgG, and moderate to severe functional disability contributed to the development of chronicity.
- Open Access
- 17 February 2021
- Published by IntechOpen
Acidosis and Anion Gap
The journey of exploring acid and base starts long before, but much advancement was seen in the last century. In 1890, Wilhelm Ostwald electronically measured hydrogen. Svante Arrhenius won the Noble prize in 1903 for the theory of ionization. In 1908, Henderson and Black showed that bicarbonate and phosphate equilibrate with CO2 at normal body temperature. In 1923, Bronsted first put forward the idea of acid that ionizes in solution and donate hydrogen and the base accepts the hydrogen from the solution. Handerson invented the important bicarbonate buffer system and Hasselbalch First measured the actual blood pH. In 1909, S. P. S. Sorensen developed the pH scale. Later Hasselbalch-Henderson developed an equation that helped in relating pH to the blood bicarbonate and PCO2. Acidosis has fatal consequences like CNS damage and death. Acidosis is rapidly stabilized by the body buffer systems. There are equal amounts of cations and anions in blood, but some of them are unmeasured. These unmeasured ions are mostly anions that produce an anion gap. Increased anion gap usually represents metabolic acidosis. Albumin and many other confounding factors influence the anion gap derangements. Accuracy in measuring anion gap is critically important for the evaluation of acidosis.
- 17 February 2021
- Published by IntechOpen
Open AccessAcidosis and Anion Gap
The journey of exploring acid and base starts long before, but much advancement was seen in the last century. In 1890, Wilhelm Ostwald electronically measured hydrogen. Svante Arrhenius won the Noble prize in 1903 for the theory of ionization. In 1908, Henderson and Black showed that bicarbonate and phosphate equilibrate with CO2 at normal body temperature. In 1923, Bronsted first put forward the idea of acid that ionizes in solution and donate hydrogen and the base accepts the hydrogen from the solution. Handerson invented the important bicarbonate buffer system and Hasselbalch First measured the actual blood pH. In 1909, S. P. S. Sorensen developed the pH scale. Later Hasselbalch-Henderson developed an equation that helped in relating pH to the blood bicarbonate and PCO2. Acidosis has fatal consequences like CNS damage and death. Acidosis is rapidly stabilized by the body buffer systems. There are equal amounts of cations and anions in blood, but some of them are unmeasured. These unmeasured ions are mostly anions that produce an anion gap. Increased anion gap usually represents metabolic acidosis. Albumin and many other confounding factors influence the anion gap derangements. Accuracy in measuring anion gap is critically important for the evaluation of acidosis.
- Open Access
- 11 December 2019
- Published by Springer Nature in Clinical Rheumatology
- Vol. 39 (4) , 1315-1323
The knowledge level of rheumatoid arthritis patients about their disease in a developing country. A study in 168 Bangladeshi RA patients
Objectives: To assess disease-related knowledge of rheumatoid arthritis (RA) patients Patients and methods: Consecutive RA patients were invited from the rheumatology departments of BSMM University, Dhaka, Bangladesh. The Bangla version of the Patient Knowledge Questionnaire (B-PKQ) was used. Correlations between the B-PKQ scores and clinical-demographic data were measured using Pearson’s correlation coefficient. Impact of independent variables on the level of knowledge about RA was analyzed through multiple regression analysis. Possible explanatory variables included the following: age, disease duration, formal education level, and Bangla Health Assessment Questionnaire (B-HAQ) score. Analysis of variance (ANOVA) was used to test the difference between demographical, clinical, and socioeconomic variables. For statistical analysis, SPSS statistics version 20 was used. Results: A total of 168 RA patients could be included. The mean B-PKQ score was 9.84 (range 1–20) from a possible maximum of 30. The mean time for answering the questionnaire was 24.3 min (range 15–34). Low scores were observed in all domains but the lowest were in medications and joint protection/energy conservation. Knowledge level was higher (15.5) in 6 patients who had RA education before enrollment. B-PKQ showed positive correlation with education level (r = 0.338) and negative correlation with HAQ (r = −0.169). The B-PKQ showed no correlation with age, disease duration, having first degree family member with RA, education from other sources (neighbor, RA patient, nurses), or information from mass media. Conclusions: Disease-related knowledge of Bangladeshi RA patients was poor in all domains. Using these findings, improved education and knowledge will result in better disease control. Key Points• Little is known about the knowledge of RA patients regarding their disease and its treatment in Bangladesh and in developing countries in general.• We found that the knowledge of Bangladeshi RA patients regarding their disease was poor in all domains; it correlated positive with education level and negative with function (HAQ), but showed no correlation with age or disease duration.• The findings of this study can be used for improving current patient education programs by health professionals and through mass media.• Better disease control of RA may be achieved by improving patient knowledge in a developing country like Bangladesh, but also in other parts of the world.
- 11 December 2019
- Published by Springer Nature in Clinical Rheumatology
- Vol. 39 (4) , 1315-1323
Open AccessThe knowledge level of rheumatoid arthritis patients about their disease in a developing country. A study in 168 Bangladeshi RA patients
Objectives: To assess disease-related knowledge of rheumatoid arthritis (RA) patients Patients and methods: Consecutive RA patients were invited from the rheumatology departments of BSMM University, Dhaka, Bangladesh. The Bangla version of the Patient Knowledge Questionnaire (B-PKQ) was used. Correlations between the B-PKQ scores and clinical-demographic data were measured using Pearson’s correlation coefficient. Impact of independent variables on the level of knowledge about RA was analyzed through multiple regression analysis. Possible explanatory variables included the following: age, disease duration, formal education level, and Bangla Health Assessment Questionnaire (B-HAQ) score. Analysis of variance (ANOVA) was used to test the difference between demographical, clinical, and socioeconomic variables. For statistical analysis, SPSS statistics version 20 was used. Results: A total of 168 RA patients could be included. The mean B-PKQ score was 9.84 (range 1–20) from a possible maximum of 30. The mean time for answering the questionnaire was 24.3 min (range 15–34). Low scores were observed in all domains but the lowest were in medications and joint protection/energy conservation. Knowledge level was higher (15.5) in 6 patients who had RA education before enrollment. B-PKQ showed positive correlation with education level (r = 0.338) and negative correlation with HAQ (r = −0.169). The B-PKQ showed no correlation with age, disease duration, having first degree family member with RA, education from other sources (neighbor, RA patient, nurses), or information from mass media. Conclusions: Disease-related knowledge of Bangladeshi RA patients was poor in all domains. Using these findings, improved education and knowledge will result in better disease control. Key Points• Little is known about the knowledge of RA patients regarding their disease and its treatment in Bangladesh and in developing countries in general.• We found that the knowledge of Bangladeshi RA patients regarding their disease was poor in all domains; it correlated positive with education level and negative with function (HAQ), but showed no correlation with age or disease duration.• The findings of this study can be used for improving current patient education programs by health professionals and through mass media.• Better disease control of RA may be achieved by improving patient knowledge in a developing country like Bangladesh, but also in other parts of the world.
- Open Access
- 1 June 2019
- Published by Elsevier in Annals of the Rheumatic Diseases
- Vol. 78 (Suppl 2) , 1318
SAT0457 PATTERNS AND CONSEQUENCES OF POST-CHIKUNGUNYA ARTHRITIS – A LONGITUDINAL STUDY IN A TERTIARY CARE HOSPITAL IN BANGLADESH
Background: Chikungunya fever (CF), is a viral illness, characterized by 3–7 days of high fever, headache, rash, myalgia, and severe arthralgias/arthritis, the hallmark of the disease.1 There is evidence that links Chikungunya infection (CHIKV) with development of unspecific Post-Viral Arthritis, Rheumatoid Arthritis, Seronegative Spondylitis and other non-inflammatory musculoskeletal complaints like persistent arthralgia.2 Objectives: To identify the clinical patterns and consequences of Post-Chikungunya arthritis. Methods: This longitudinal study was carried out during a major out-break of CHIKV infection in Dhaka, Bangladesh, among 142 patients (CHIKV IgM and/or IgG positive) who were followed-up for the next one year. Their clinical, laboratory, radiographic and ultrasonographic features were evaluated. Functional status was assessed by validated Bengali version of Health Assessment Questionnaire (HAQ). Results: The mean age of the patient’s was 43.12 ±10.94 where 50.7% were male and 81.7% were urban resident. At presentation (D1),95.1% patients were Chikungunya IgM positive where as 20.4% were IgG positive. Polyarthritis was noted among 69.7% patients. Symmetrical joint involvement and joint swelling were present in 84.5% in 47.2% patients respectively. The mean HAQ score was 1.34±0.72. After 3 months (D90) follow up, 40.8% patients reported Chronic Chikungunya arthritis where 6.9% had Rheumatoid Arthritis, 3.4% had Spondyloarthropathy and 89.6% were Undifferentiated arthritis. Among the Chronic Chikungunya arthritis patients, 5.2% were Anti-CCP positive, 1.7% were Rheumatoid factor positive, 3.4% were HLA-B27 positive and 3.4% had X-Ray findings of bilateral Sacroiliitis. Patients were treated with NSAID (100.0%) and steroid (10.0%) initially. Chronic arthritis was treated with Sulfasalazine (12.0%), Methotrexate (7.0%) and Tofacitinib (3.4%). Conclusion: This study demonstrated that chronic arthritis was a frequent complication of acute Chikungunya infection where majority had undifferentiated arthritis. References [1] Brighton SW, Prozesky OW, de la Harpe AL (1983) Chikungunya virus infection — a retrospective study of 107 cases. S Afr Med J63,313-5. [2] Yaseen HM, Simon F, Deparis X, Marimoutou C (2014) Identification of initial severity determinants to predict arthritis after chikungunya infection in a cohort of French gendarmes. BMC musculoskeletal disorders15,249. Clinical presentation of the patients at onset (n=142) Disclosure of Interests: None declared
- 1 June 2019
- Published by Elsevier in Annals of the Rheumatic Diseases
- Vol. 78 (Suppl 2) , 1318
Open AccessSAT0457 PATTERNS AND CONSEQUENCES OF POST-CHIKUNGUNYA ARTHRITIS – A LONGITUDINAL STUDY IN A TERTIARY CARE HOSPITAL IN BANGLADESH
Background: Chikungunya fever (CF), is a viral illness, characterized by 3–7 days of high fever, headache, rash, myalgia, and severe arthralgias/arthritis, the hallmark of the disease.1 There is evidence that links Chikungunya infection (CHIKV) with development of unspecific Post-Viral Arthritis, Rheumatoid Arthritis, Seronegative Spondylitis and other non-inflammatory musculoskeletal complaints like persistent arthralgia.2 Objectives: To identify the clinical patterns and consequences of Post-Chikungunya arthritis. Methods: This longitudinal study was carried out during a major out-break of CHIKV infection in Dhaka, Bangladesh, among 142 patients (CHIKV IgM and/or IgG positive) who were followed-up for the next one year. Their clinical, laboratory, radiographic and ultrasonographic features were evaluated. Functional status was assessed by validated Bengali version of Health Assessment Questionnaire (HAQ). Results: The mean age of the patient’s was 43.12 ±10.94 where 50.7% were male and 81.7% were urban resident. At presentation (D1),95.1% patients were Chikungunya IgM positive where as 20.4% were IgG positive. Polyarthritis was noted among 69.7% patients. Symmetrical joint involvement and joint swelling were present in 84.5% in 47.2% patients respectively. The mean HAQ score was 1.34±0.72. After 3 months (D90) follow up, 40.8% patients reported Chronic Chikungunya arthritis where 6.9% had Rheumatoid Arthritis, 3.4% had Spondyloarthropathy and 89.6% were Undifferentiated arthritis. Among the Chronic Chikungunya arthritis patients, 5.2% were Anti-CCP positive, 1.7% were Rheumatoid factor positive, 3.4% were HLA-B27 positive and 3.4% had X-Ray findings of bilateral Sacroiliitis. Patients were treated with NSAID (100.0%) and steroid (10.0%) initially. Chronic arthritis was treated with Sulfasalazine (12.0%), Methotrexate (7.0%) and Tofacitinib (3.4%). Conclusion: This study demonstrated that chronic arthritis was a frequent complication of acute Chikungunya infection where majority had undifferentiated arthritis. References [1] Brighton SW, Prozesky OW, de la Harpe AL (1983) Chikungunya virus infection — a retrospective study of 107 cases. S Afr Med J63,313-5. [2] Yaseen HM, Simon F, Deparis X, Marimoutou C (2014) Identification of initial severity determinants to predict arthritis after chikungunya infection in a cohort of French gendarmes. BMC musculoskeletal disorders15,249. Clinical presentation of the patients at onset (n=142) Disclosure of Interests: None declared
- Open Access
- 14 February 2019
- Published by Bangladesh Academy of Sciences in Bangladesh Medical Journal
- Vol. 46 (2) , 53-55
Pigmented Villonodular Synovitis Treated as Spondyloarthritis for Four Years- A Case Report
Pigmented villonodular synovitis (PVNS) is a rare disorder where abnormal synovial proliferation and insidious swelling are the characteristic features. As insidious joint swelling has many common causes and PVNS is rare entity, so that it may be missed or under evaluated. Here inconclusive biopsy findings at an early stage and features resembling spondyloarthritis (SpA) delayed the diagnosis. A 28-year-old young man presented with insidious swelling of knee. Here repeated aspiration and synovial fluid analysis with routine serological and radiological examination were inconclusive. Then he was labeled and treated as spondyloarthritis (SpA) for four years without improvement. After four years of sufferings he admitted here and reached the diagnosis of PVNS with the help of MRI and synovial biopsy. Sometimes rare disease diagnosis is complicated by the absence of typical features and inconclusive reports. Common differentials may mimic the diagnosis and rare disease may loss the attention. Here PVNS was treated as SpA for four years before being diagnosed. Bangladesh Med J. 2017 May; 46 (2): 53-55
- 14 February 2019
- Published by Bangladesh Academy of Sciences in Bangladesh Medical Journal
- Vol. 46 (2) , 53-55
Open AccessPigmented Villonodular Synovitis Treated as Spondyloarthritis for Four Years- A Case Report
Pigmented villonodular synovitis (PVNS) is a rare disorder where abnormal synovial proliferation and insidious swelling are the characteristic features. As insidious joint swelling has many common causes and PVNS is rare entity, so that it may be missed or under evaluated. Here inconclusive biopsy findings at an early stage and features resembling spondyloarthritis (SpA) delayed the diagnosis. A 28-year-old young man presented with insidious swelling of knee. Here repeated aspiration and synovial fluid analysis with routine serological and radiological examination were inconclusive. Then he was labeled and treated as spondyloarthritis (SpA) for four years without improvement. After four years of sufferings he admitted here and reached the diagnosis of PVNS with the help of MRI and synovial biopsy. Sometimes rare disease diagnosis is complicated by the absence of typical features and inconclusive reports. Common differentials may mimic the diagnosis and rare disease may loss the attention. Here PVNS was treated as SpA for four years before being diagnosed. Bangladesh Med J. 2017 May; 46 (2): 53-55